Anzemet and Tooth impacted - a phase IV clinical study of FDA data

Summary:

Tooth impacted is reported as a side effect among people who take Anzemet (dolasetron mesylate), especially for people who are male, 50-59 old, also take Aredia, and have Metastases to bone.

The phase IV clinical study analyzes which people have Tooth impacted when taking Anzemet. It is created by eHealthMe based on reports of 2,574 people who have side effects when taking Anzemet from the FDA, and is updated regularly.

What is Anzemet?

Anzemet has active ingredients of dolasetron mesylate. eHealthMe is studying from 2,603 Anzemet users. Check the latest studies of Anzemet.

What is Tooth impacted?

Tooth impacted (a tooth that fails to fully pass through the gums) is found to be associated with 259 drugs and 194 conditions by eHealthMe. Check the latest studies of Tooth impacted.



On Jul, 05, 2026

2,574 people reported to have side effects when taking Anzemet.
Among them, 36 people (1.4%) have Tooth impacted.

Could Anzemet cause Tooth impacted?

Among these 36 people:

What is the gender of people who have Tooth impacted when taking Anzemet? *

  • female: 44.44 %
  • male: 55.56 %

What is the age of people who have Tooth impacted when taking Anzemet? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 35.29 %
  • 50-59: 35.29 %
  • 60+: 29.41 %

What are other drugs people take besides Anzemet? *

  1. Zometa: 36 people, 100.00%
  2. Aredia: 36 people, 100.00%
  3. Prilosec: 29 people, 80.56%
  4. Aloxi: 21 people, 58.33%
  5. Ambien: 21 people, 58.33%
  6. Diflucan: 19 people, 52.78%
  7. Toprol-Xl: 19 people, 52.78%
  8. Dexamethasone: 19 people, 52.78%
  9. Gemzar: 18 people, 50.00%
  10. Taxotere: 18 people, 50.00%

What are other side effects people have besides Tooth impacted? *

  1. Dental Caries: 33 people, 91.67%
  2. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 29 people, 80.56%
  3. Pain: 28 people, 77.78%
  4. Osteomyelitis (infection of bone): 27 people, 75.00%
  5. High Blood Pressure: 25 people, 69.44%
  6. Diarrhea: 25 people, 69.44%
  7. Pleural Effusion (water on the lungs): 25 people, 69.44%
  8. Spinal Osteoarthritis (joint cartilage loss in spine): 24 people, 66.67%
  9. Anaemia (lack of blood): 23 people, 63.89%
  10. Metastases To Liver (cancer spreads to liver): 23 people, 63.89%

What are the existing conditions these people have? *

  1. Metastases To Bone (cancer spreads to bone): 23 people, 63.89%
  2. Breast Cancer: 15 people, 41.67%
  3. Parkinson's Disease: 10 people, 27.78%
  4. Osteoporosis (bones weak and more likely to break): 10 people, 27.78%
  5. Osteopenia (a condition where bone mineral density is lower than normal): 10 people, 27.78%
  6. Pain: 8 people, 22.22%
  7. Multiple Myeloma (cancer of the plasma cells): 7 people, 19.44%
  8. Quit Smoking: 1 person, 2.78%
  9. Neuropathy Peripheral (surface nerve damage): 1 person, 2.78%
  10. Hypercalcaemia (elevated calcium (ca+) level in the blood): 1 person, 2.78%

* Approximation only. Some reports may have incomplete information.

Do you take Anzemet and have Tooth impacted?

- Check whether Tooth impacted is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Anzemet:

Tooth impacted treatments and more:

How severe was Tooth impacted and when was it recovered:

Expand to all the drugs that have ingredients of dolasetron mesylate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Anzemet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tooth impacted:

Browse all the conditions that are associated with Tooth impacted:


How the study uses the data?

The study uses data from the FDA. It is based on dolasetron mesylate (the active ingredients of Anzemet) and Anzemet (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: